It Kills That: Cramer Won’t Recommend Pfizer 7% Yield
Jim Cramer declines to back Pfizer despite its 7% dividend, arguing the growth case isn’t clear. Pfizer sits near a 5...
An accessible primer on stock index levels, detailing what they represent, how they’re calculated, and why they matter for portfolio assessment.
20,792 articlesJim Cramer declines to back Pfizer despite its 7% dividend, arguing the growth case isn’t clear. Pfizer sits near a 5...
As AMD prepares to report its second-quarter results, a bullish outlook centered on AI demand could dominate the conv...
AI is changing how businesses operate and scale. This guide highlights three top here artificial intelligence stocks ...
A major institution disclosed a new roughly $5 million stake in Central Bancompany, helping fuel a 20% gain since its...
This comprehensive guide breaks down mirum (mirm) 2025 earnings, translating earnings calls into actionable numbers. ...
Asana's 2026 earnings outlook blends strong ARR growth with improving efficiency. This guide breaks down the key numb...
When market swings unsettle investors, reliable dividend stocks double right can stabilize returns. Here are two prov...
March is a pivotal time for industrial stocks as infrastructure and defense themes collide with energy transition dem...
Since 2020, five magnificent stocks have split their shares. Only Alphabet and Tesla outpaced the market, proving tha...
Goldman Sachs flags three natural gas stocks as strong buy candidates as LNG demand tightens and energy markets swing.
With $100, you can start building a resilient energy stock portfolio. This guide breaks down the smartest energy stoc...
A West Coast airline pilot gains approval to slash his own 401(k) contributions after his employer offers a 17% match...